GCM格罗夫纳

US · GCMG #3427 按市值排名上市于 2020

12.56 -0.30 -2.33%

实时 - 追踪5344个代码 - 心跳于17秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了2家。
机构持股总比例下降了8.6个百分点。

机构持股

机构持股比例: 93.96% -8.57pp
机构数量: 181 -2
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund78.40%

Hedge Fund7.44%

Public Company6.99%

Individual/Insider2.82%

Private Company0.38%

Sovereign Wealth Fund0.32%

Government Pension Fund0.22%

Insurance Company0.17%

Other3.23%

主要股东截至 2026-07-16

Cantor Fitzgerald Asset Management 9.64% · 5.89M 股

Columbia Management Investment Advisers, LLC 8.83% · 5.40M 股

BlackRock 7.79% · 4.76M 股

Ariel Investments, LLC 7.22% · 4.42M 股

Sumitomo Mitsui Trust Asset Management 6.14% · 3.75M 股

Vanguard Capital Management, LLC 4.93% · 3.01M 股

Vanguard Portfolio Management, LLC 4.32% · 2.64M 股

Mizuho Financial Group, Inc. 3.98% · 2.43M 股

Baron Capital Group, Inc. 3.61% · 2.20M 股

Royce & Associates, LP 2.92% · 1.78M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 28次买入 · 22次卖出

姓名	职务	持股比例
Frederick Pollock	MD, Chief Investment Officer & Head of Strategic Investment Group	1.33%
Jonathan Levin	President, MD & Director	1.13%
Francesca Cornelli	Independent Director	0.09%
Sandra Hurse	MD & Chief Human Resources Officer	0.08%
Angela Blanton	Independent Director	0.07%
Kathleen Sullivan	Head of Accounting & Financial Reporting and MD of Finance in Chicago	0.07%
Pamela Bentley	MD & CFO	0.02%
Samuel Scott	Lead Independent Director	0.02%
David Helfand	Independent Director	--
Howard Lutnick	--	--

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-29	David Helfand	Independent Director	Other Derivative Acquisition	+6,886	--
2026-09-29	Samuel Scott	Lead Independent Director	Other Derivative Acquisition	+5,722	--
2026-09-29	Francesca Cornelli	Independent Director	Other Acquisition	+5,722	$12.89
2026-09-29	Stephen Malkin	Non-Independent Director	Other Derivative Acquisition	+4,849	--
2026-09-15	Pamela Bentley	MD & CFO	Automatic Disposition	-50,000	$12.56–12.68
2026-09-15	Pamela Bentley	MD & CFO	Intent to Sell (Form 144)	-10,000	$12.76
2026-09-14	Pamela Bentley	MD & CFO	Intent to Sell (Form 144)	-40,000	$12.64
2026-09-02	Kathleen Sullivan	Head of Accounting & Financial Reporting and MD of Finance in Chicago	Open Market Disposition	-40,000	$13.15–13.16
2026-08-14	Jonathan Levin	President, MD & Director	Derivative Exercise and Sale	-42,813	$13.86
2026-08-14	Jonathan Levin	President, MD & Director	Derivative Exercise and Retained	+48,492	--
2026-08-14	Frederick Pollock	MD, Chief Investment Officer & Head of Strategic Investment Group	Derivative Exercise and Sale	-23,953	$13.86
2026-08-14	Frederick Pollock	MD, Chief Investment Officer & Head of Strategic Investment Group	Derivative Exercise and Retained	+36,917	--
2026-07-15	Cantor Fitzgerald Asset Management	--	Open Market Disposition	-553,106	$13.57–13.83
2026-07-14	Cantor Fitzgerald Asset Management	--	Private Disposition	-4,000	$14.24
2026-06-29	David Helfand	Independent Director	Other Derivative Acquisition	+7,216	--
2026-06-29	Samuel Scott	Lead Independent Director	Other Derivative Acquisition	+5,996	--
2026-06-29	Francesca Cornelli	Independent Director	Other Acquisition	+5,996	$12.30
2026-06-29	Stephen Malkin	Non-Independent Director	Other Derivative Acquisition	+5,082	--
2026-05-30	Jonathan Levin	President, MD & Director	Derivative Exercise and Sale	-45,085	$10.63
2026-05-30	Jonathan Levin	President, MD & Director	Derivative Exercise and Retained	+54,157	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。